Article Text
Editorial
Type 2 myocardial infarction: the need to operationalise diagnostic criteria and shift towards clinical trials
Statistics from Altmetric.com
Footnotes
Twitter @yadersandoval
Contributors YS wrote the editorial.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests YS: Abbott Diagnostics, Roche Diagnostics, Philips and Zoll. Patent 20210401347.
Provenance and peer review Commissioned; internally peer reviewed.